HAL (France)open access
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results
Moderately to Severely Active Ulcerative Colitis, Inflammatory Bowel Disease, 0, Clinical Trial Result, Monoclonal Antibody, Adalimumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 643352
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.